Journal
PHARMACOGENOMICS
Volume 19, Issue 7, Pages 667-685Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/pgs-2017-0207
Keywords
genotype-guided dosing algorithms; pharmacogenetic-based algorithm; pharmacogenetics; polymorphisms; vitamin k antagonist; warfarin
Categories
Funding
- Sao Paulo Research Foundation (FAPESP) [2013/09295-3, 2016/22507-8, 2016/23454-5]
Ask authors/readers for more resources
Warfarin pharmacogenomics has been an extensively studied field in the last decades as it is focused on personalized therapy to overcome the wide interpatient warfarin response variability and decrease the risk of side effects. In this expert review, besides briefly summarizing the current knowledge about warfarin pharmacogenetics, we also present an overview of recent studies that aimed to assess the efficacy, safety and economic issues related to genotype-based dosing algorithms used to guide warfarin therapy, including randomized and controlled clinical trials, meta-analyses and cost-effectiveness studies. To date, the findings still present disparities, mostly because of standard limitations. Thus, further studies should be encouraged to try to demonstrate the benefits of the application of warfarin pharmacogenomic dosing algorithms in clinical practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available